Rottendorf wiederholt von der ANVISA freigegeben

Rottendorf Pharma GmbH

Rottendorf Pharma is an independent and worldwide operating Technical Operations Organization for development, manufacturing and packaging of solid dosage forms.Besides the two sites in Germany the company is also represented by a subsidiary, Rottendorf Pharma S.A.S., in Valenciennes/France as well as in Chicago as Rottendorf Pharma Inc..

As a specialist for the manufacturing of tablets, pellets, capsules, sugar coated tablets and film coated tablets Rottendorf assumes total process ownership on every level of the range of services from development and manufacturing up to packaging and distribution along the supply chain. This is supported by GMP-and FDA conform equipment and state-of the art technologies such as hot melt extrusion and hot melt granulation.

Rottendorf´s exceptional company structure and the fact that it is part of a
non-profit foundation guarantees to its customers long term sustainability, retaining of total independency and maximal production reliability and investment security.
Due to annual investments of several million Euros of all profits being reinvested into business growth, subsequent modernization and expansion of the facilities and technologies are ensured. Therefore Rottendorf is not only focused on market success but also on social engagement.

Further information is available on the internet at www.rottendorf.de.